Telemedicine in HIV Care in Buenos Aires

Delivery of HIV Care Through Telemedicine in Public Hospitals in Buenos Aires, Argentina During COVID-19 Pandemic: Implementation Research

The aim of this investigation is to conduct an implementation research to facilitate and evaluate the implementation of VCT((Videoconsult through telemedicine) among HIV HCP(healthcare providers) and PLWH(people living with HIV)

Study Overview

• Status: Unknown
• Conditions: Telemedicine; HIV-1-infection

Detailed Description

Through prospective observational methodology the investigators are planning to evaluate VCT(Videoconsult through telemedicine) implementation. Both quantitative and qualitative analysis (mixed methods) will take part in the assessment. Quantitative data will be useful to obtain objective data in terms of proportion of subjects using the intervention, adoption by health care workers and measuring effectiveness. Additionally, qualitative methods will help to understand the outcomes focusing on the barriers and facilitators from both the HCW and patients, and their feedback on continuous implementation.

Hence, perceptions of a vast group of patients and HCW will take a critical point in the qualitative analysis. Finally, by evidencing effectiveness, the investigators will be able to generalize and maintain this intervention as a good clinical practice. Due to the scope of the outcomes, the investigators will use RE-AIM framework.

• Study Type: Observational
• Enrollment (Anticipated): 4000

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

PLWH(people living with HIV) that receive care in Buenos Aires public hospitals

Description

Inclusion Criteria:

• 18 years-old or older
• Access to internet
• Willing to participate

Exclusion Criteria:

• do not understand the purpose and study procedures

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Telemedicine Reach. RE-AIM framework	Proportion of included patients over all patients eligible	18 months
Telemedicine Effectiveness. RE-AIM framework	Proportion of treatment interruptions and undetectable HIV viral load	18 months
Telemedicine Adoption. RE-AIM framework	Proportion of physicians adopting VC, barriers and facilitators to adopt telemedicine	18 months
Telemedicine Implementation.RE-AIM framework	Time and cost needed to deliver the intervention	18 months
Telemedicine Manteinance. RE-AIM framework	Inclusion of VCT into routine activity, Satisfaction of HCP(healthcare proffesionals and patients with videoconsultation	18 months

Collaborators and Investigators

• Sponsor: Fundacion Ibis

Study record dates

Study Major Dates

• Study Start (Anticipated): September 1, 2020
• Primary Completion (Anticipated): March 1, 2022
• Study Completion (Anticipated): July 1, 2022

Study Registration Dates

• First Submitted: August 4, 2020
• First Submitted That Met QC Criteria: August 13, 2020
• First Posted (Actual): August 14, 2020

Study Record Updates

• Last Update Posted (Actual): August 14, 2020
• Last Update Submitted That Met QC Criteria: August 13, 2020
• Last Verified: August 1, 2020

More Information

Terms related to this study

• Other Study ID Numbers: TM HIV BA

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No